osteoporosis%20in%20women
OSTEOPOROSIS IN WOMEN
Osteoporosis is a progressive, systemic, skeletal disease characterized by decreased bone mass and microarchitectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history of fracture, advanced age, comorbidities, etc) that are present, the greater the risk of fracture.

Surgical Intervention

  • Eg vertebroplasty, kyphoplasty
  • Management of osteoporotic fractures should involve both non-pharmacological and pharmacological treatment of osteoporosis, management of pain, and surgery only if necessary
  • Considered when treatment of acute symptomatic vertebral fractures are nonresponsive to conservative treatments
    • Not to be used as 1st-line treatment of vertebral fractures due to increased risk of fractures in adjacent vertebrae
  • Several studies have shown improvement in back pain after treatment with vertebroplasty cement augmentation
  • Kyphoplasty may partially reverse vertebral deformities and provide relief from pain
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Early screening for gestational diabetes does not improve the composite perinatal outcomes in obese women, reveals a study.
Audrey Abella, 6 days ago
A novel, investigational vaginal pH regulator (VPR) – a nonhormonal, water-based, petroleum-free contraceptive vaginal gel – improved genitourinary (GU) side effects and sexual satisfaction in women who are at risk of pregnancy but are not aiming to conceive, interim findings from the phase III AMPOWER* trial show.
Pearl Toh, 21 May 2020
A levonorgestrel (LNG)-releasing intrauterine device (IUD) maintains high contraceptive efficacy up to 6 years, which is beyond the 5-year period it is currently approved for, according to data from the Mirena Extension Trial (MET) released during the ACOG 2020 Meeting.